Align Technology Receives Expanded Regulatory Approval in Japan

Tuesday, December 9, 2008 General News J E 4
SANTA CLARA, Calif., Dec. 8 Align Technology,Inc. (Nasdaq: ALGN) today announced that it has received regulatory approvalfrom the Japanese Ministry of Health, Labour and Welfare (MHLW). The Companymay now begin widespread marketing and promotion of Invisalign in Japan, whereit has trained approximately 660 Invisalign orthodontists since launching theproduct there in October, 2005.

"This regulatory approval in Japan is an important milestone and willenable us to engage in more traditional and expansive outreach activities toeducate and support dental professionals with the necessary marketingactivities needed to build the market for Invisalign in Japan," said Gil Laks,vice president of International. "In addition, we can now leverage thestrength of the Invisalign brand by targeting prospective patients in Japanwith consumer demand creation programs."

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, aproprietary method for treating malocclusion, or the misalignment of teeth.Invisalign corrects malocclusion using a series of clear, nearly invisible,removable appliances that gently move teeth to a desired final position.Because it does not rely on the use of metal or ceramic brackets and wires,Invisalign significantly reduces the aesthetic and other limitationsassociated with braces. Invisalign is appropriate for treating adults andteens. Align Technology was founded in March 1997 and received FDA clearanceto market Invisalign in 1998. Today, the Invisalign product family includesInvisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and ViveraRetainers.

To learn more about Invisalign or to find a certified Invisalign doctor inyour area, please visit or call 1-800-INVISIBLE.Investor Relations Contact Press Contact Shirley Stacy Shannon Mangum Henderson Align Technology, Inc. Ethos Communication, Inc. (408) 470-1150 (678) 540-9222

SOURCE Align Technology, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
AstraZeneca and Targacept Announce Top-Line Result...
Advisory: Report Card of State Preparedness for Bi...